[#item_full_content]ASHBURN, Va.–(BUSINESS WIRE)–In an ambitious move to transform wound care, Magle Chemoswed and I2Pure have unveiled a joint venture, marrying I2Pure’s groundbreaking molecular iodine technology with Magle Chemoswed’s innovative starch microspheres. This collaboration is poised to address critical patient needs and significantly enhance treatment outcomes in wound care. I2Pure, known for its dedication to infection prevention through non-toxic molecular iodine technology, joins forces with Mag